PARP inhibitors in cancer therapy: Two modes of attack on the cancer cell widening the clinical applications
To access this article, please choose from the options below
PII: S1368-7646(09)00063-6
doi:10.1016/j.drup.2009.10.001
© 2009 Elsevier Ltd. All rights reserved.
